Related Experiment Videos
Cocrystal structure of protein farnesyltransferase complexed with a farnesyl diphosphate substrate
S B Long1, P J Casey, L S Beese
1Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, USA.
Abstract:
Protein farnesyltransferase (FTase) catalyzes the transfer of the hydrophobic farnesyl group from farnesyl diphosphate (FPP) to cellular proteins such as Ras at a cysteine residue near their carboxy-terminus. This process is necessary for the subcellular localization of these proteins to the plasma membrane and is required for the transforming activity of oncogenic variants of Ras, making FTase a prime target for anticancer therapeutics. The high-resolution crystal structure of rat FTase was recently determined, and we present here the X-ray crystal structure of the first complex of FTase with a FPP substrate bound at the active site. The isoprenoid moiety of FPP binds in an extended conformation in a hydrophobic cavity of the beta subunit of the FTase enzyme, and the diphosphate moiety binds to a positively charged cleft at the top of this cavity near the subunit interface. The observed location of the FPP molecule is consistent with mutagenesis data. This binary complex of FTase with FPP leads us to suggest a "molecular ruler" hypothesis for isoprenoid substrate specificity, where the depth of the hydrophobic binding cavity acts as a ruler discriminating between isoprenoids of differing lengths. Although other length isoprenoids may bind in the cavity, only the 15-carbon farnesyl moiety binds with its C1 atom in register with a catalytic zinc ion as required for efficient transfer to the Ras substrate.
Insights
Protein farnesyltransferase (FTase) is a target for cancer drugs. We determined the crystal structure of FTase bound to its farnesyl diphosphate (FPP) substrate, revealing how it binds and its specificity.
Area of Science:
- Biochemistry
- Structural Biology
- Enzymology
Background:
- Protein farnesyltransferase (FTase) is crucial for prenylated protein function, including Ras oncogenes.
- FTase is a key target for anticancer drug development due to its role in oncogenic Ras.
- Recent determination of rat FTase crystal structure provides a basis for structural studies.
Purpose of the Study:
- To elucidate the binding mode of farnesyl diphosphate (FPP) to FTase.
- To understand the structural basis of FTase substrate specificity.
- To provide insights for the rational design of FTase inhibitors.
Main Methods:
- X-ray crystallography
- Protein-substrate complex formation
- Structural analysis
Main Results:
- The crystal structure of the FTase-FPP binary complex was determined.
- FPP binds in an extended conformation within a hydrophobic cavity of the FTase beta subunit.
- The diphosphate moiety of FPP binds to a positively charged cleft near the subunit interface.
- A "molecular ruler" hypothesis for isoprenoid substrate specificity is proposed based on cavity depth.
- Specific binding of the 15-carbon farnesyl moiety is observed, with C1 in register with a catalytic zinc ion.
Conclusions:
- The FTase-FPP complex structure reveals key interactions governing substrate binding.
- The hydrophobic cavity depth acts as a molecular ruler for isoprenoid specificity.
- Structural insights support the development of targeted anticancer therapeutics inhibiting FTase.